ACZONE® (dapsone) Gel 5%
Special online savings for ACZONE® (dapsone) Gel 5%!
Most Insured Patients Pay No More Than:Best value for your co-pay! | Ask for the 90g tube.1st prescription $25†2nd prescription $15†3rd prescription $0†
Valid for patients with commercial prescription insurance only.
Offer is available for 30-, 60-, and 90-gram tubes.
Limitations apply. See copy directly below the IMPORTANT SAFETY INFORMATION for more details, terms and conditions and eligibility.
Good for up to three (3) uses.
FDA-APPROVED USE

ACZONE® Gel is a prescription medicine used on your skin (topical) to treat acne in people 12 years and older.

IMPORTANT SAFETY INFORMATION

Do not use ACZONE® Gel if you are allergic to any of the ingredients in ACZONE® Gel or if you are younger than 12 years of age.

Tell your doctor about all of your medical conditions, including if you have glucose-6-phosphate dehydrogenase deficiency (G6PD) which may put you at a greater risk for developing a low red blood cell count. If you experience signs and symptoms such as back pain, breathlessness, tiredness/weakness with daily activities, dark-brown urine, high fever, and yellow or pale skin, stop use and call your doctor immediately.

The most common side effects of ACZONE® Gel are dryness, redness, oiliness, and peeling of the skin being treated.

Talk to your doctor about any medications you’re using including topical benzoyl peroxide (BPO). Use of BPO with ACZONE® Gel may cause your skin to temporarily turn yellow or orange at the site of application.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information


Valid for 30-, 60-, or 90-gram tubes.

Valid for patients with commercial prescription insurance only.

This offer is good for up to three (3) uses. Present savings card to the pharmacist along with your prescription for ACZONE® (dapsone) Gel 5%. Insured patients pay $25 and save up to $185 for their first prescription, pay $15 and save up to $195 for their second prescription, and pay $0 and save up to $210 for their third prescription.

Savings card must be presented at the time of fill for instant savings. For any questions, call the ACZONE® Savings Program at 1-855-439-2815.

Eligibility: According to federal and state laws, this offer is not available to patients enrolled in Medicare, Medicaid, or any other government health program, or where prohibited by law.

This promotion cannot be combined with any other programs, offers, or discounts. Offer good only in the United States. Allergan, Inc., reserves the right to rescind, revoke, and amend this offer without notice.
Offer expires June 30, 2015.

Save on your first prescription for ACZONE® (dapsone) Gel 5% and even more on refills! Which best describes your status in the ACZONE® Savings Program?
I need a savings cardI have a savings card from my doctorI lost my savings card

In order to get your online savings card, you must complete the form below.

In order to register your savings card and get your special savings, you must complete the form below.

In order to get your new online savings card, you must complete the form below.

*Indicates required field.

*How many times did you fill your ACZONE® prescription using your savings card or voucher?

0
1
2
More than 2

*Gender:

Female
Male

*I have used ACZONE® Gel:

Never
In the past
Current user

*I plan to see a doctor regarding my acne within:

1 Week
1 Month
3 Months

*I will be discussing my acne with my: (check all that apply)

*How I heard about ACZONE® Gel:(check all that apply)

*Which treatment are you currently using?(check all that apply)

By enrolling in this program, you are consenting to the collection and use of certain personal information, including, your phone number and/or email address and elements of pharmacy claim information, and to receive periodic ACZONE® Gel refill reminders and additional program messages. This information will be collected and used by service providers of ACZONE® (dapsone) Gel in order to administer this program. This information is not provided to ACZONE® Gel directly. If you do not consent, please do not enroll into the program. Text messages received within the mobile program are automated and responses are not read by any person. Message and data rates may apply. Text STOP to opt out at any time.

Ask Your Dermatologist
Talk to your dermatologist about ACZONE® Gel. If you don't have a dermatologist, we can help you find one.

Share Your Success
Share Your Acne Story
Tell us your story and share your own
ACZONE® experience.

Share My Success Story

Aczone FDA-APPROVED USE

ACZONE® Gel is a prescription medicine used on your skin (topical) to treat acne in people 12 years and older.

IMPORTANT SAFETY INFORMATION

Do not use ACZONE® Gel if you are allergic to any of the ingredients in ACZONE® Gel or if you are younger than 12 years of age.

Tell your doctor about all of your medical conditions, including if you have glucose-6-phosphate dehydrogenase deficiency (G6PD) which may put you at a greater risk for developing a low red blood cell count. If you experience signs and symptoms such as back pain, breathlessness, tiredness/weakness with daily activities, dark-brown urine, high fever, and yellow or pale skin, stop use and call your doctor immediately.

The most common side effects of ACZONE® Gel are dryness, redness, oiliness, and peeling of the skin being treated.

Talk to your doctor about any medications you’re using including topical benzoyl peroxide (BPO). Use of BPO with ACZONE® Gel may cause your skin to temporarily turn yellow or orange at the site of application.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information

  1. Draelos ZD, Carter E, Maloney JM, et al; for United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e1-439.e10.
  2. MMIT Formulary Compass, data as of April 25, 2013.